InVivoMAb anti-human GM-CSF

Clone BVD2-23B6
Catalog # BE0384
Category InVivoMab Antibodies
Price
Size Regular Price
1mg $ 159.00
5mg $ 583.00
25mg $ 1,950.00
50mg $ 2,936.00
100mg $ 4,155.00
About InVivoMAb anti-human GM-CSF

The BVD2-23B6 monoclonal antibody reacts with human granulocyte-macrophage colony-stimulating factor (GM-CSF), also known as colony stimulating factor 2 (CSF2). GM-CSF is a 14 kDa monomeric hematopoietic factor secreted by macrophages, T cells, mast cells, NK cells, endothelial cells, and fibroblasts. GM-CSF stimulates stem cells to differentiate into granulocytes (neutrophils, eosinophils, and basophils) and monocytes. The BVD2-23B6 antibody has been reported as a neutralizing antibody. 

InVivoMAb anti-human GM-CSF Specifications
IsotypeRat IgG2a, κ
Recommended Isotype Control(s)InVivoMAb rat IgG2a isotype control, anti-trinitrophenol
Recommended Dilution BufferInVivoPure pH 7.0 Dilution Buffer
MutationsD265A
ImmunogenRecombinant human GM-CSF
Reported Applicationsin vitro GM-CSF neutralization
ELISA
FormulationPBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin<2EU/mg (<0.002EU/μg)
Determined by LAL gel clotting assay
Purity>95%
Determined by SDS-PAGE
Sterility0.2 µm filtration
ProductionPurified from tissue culture supernatant in an animal free facility
PurificationProtein G
Molecular Weight150 kDa
StorageThe antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
Application References